(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-PENTANEDIOATE
Compound with spectra: 1 NMR
![(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-PENTANEDIOATE](/api/compound/Zv6AhzDfPF.png?ph=true&h=300&w=458 "(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-PENTANEDIOATE")
| SpectraBase Compound ID | Zv6AhzDfPF |
|---|---|
| InChI | InChI=1S/C13H16FN3O7/c1-23-10(19)4-3-8(12(21)24-2)15-9(18)6-17-5-7(14)11(20)16-13(17)22/h5,8H,3-4,6H2,1-2H3,(H,15,18)(H,16,20,22)/t8-/m0/s1 |
| InChIKey | IMTGZLOFMBYQIZ-QMMMGPOBSA-N |
| Mol Weight | 345.28 g/mol |
| Molecular Formula | C13H16FN3O7 |
| Exact Mass | 345.097228 g/mol |
| Enantiomer InChIKey | IMTGZLOFMBYQIZ-MRVPVSSYSA-N |
| Racemate InChIKey | IMTGZLOFMBYQIZ-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(S)-DIMETHYL-2-[2-(5-FLUORO-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-ACETAMIDO]-SUCCINATE
N-{[5-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-valine Methyl Ester
N-{[6-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-leucine Methyl Ester
(+-)-[(1SR,3RS)-2,2-difluoro-3-hydroxymethylcyclopropylmethyl]-5-fluoro1,2,3,4-tetrahydro-2,4-pyrimidindione
1 -(3 -(4 -Acetylaminobenzenesulfonamido) -3 -oxopropyl) -5 -fluoropyrimidine-2,4 -dione
N-{[6-Methyl-4-(methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-valine Methyl Ester
N-{[4-(Methylsulfanyl)-2-oxopyrimidin-1(2H)-yl]acetyl}-L-phenylglycine Methyl Ester
5-Fluoranyl-1-[3-(2-hydroxyethyloxy)-1-propan-2-yloxy-propyl]pyrimidine-2,4-dione
(+/-)-1-(p-dithian-2-yl)-5-fluorouracil
METHYL-3-METHOXY-3-(5-FLUOROURACIL-1-YL)-PROPANOATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil | Molecules | 2009 |